Estonia vs Greece: Access to anti-retroviral drugs, male
Estonia
68.0%
in 2022
Greece
68.0%
in 2024
Estonia rank
73rd
Greece rank
73rd
Access to anti-retroviral drugs, male over time
- Estonia
- Greece
How they compare
Estonia currently reports 68.0% against 68.0% in Greece, a difference of 0.0%.
The two have swapped places 2 times across 23 shared years of data; in 2000 it was Greece ahead.
Estonia ranks 73rd and Greece ranks 73rd of 141 countries.
Across the 3 decades both report, Estonia averaged higher in 1 and Greece in 2.
Head to head by decade
| Decade | Estonia | Greece | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.7% | 46.9% | 37.2% | Greece |
| 2010s | 53.6% | 61.1% | 7.5% | Greece |
| 2020s | 68.3% | 68.0% | 0.3% | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Estonia or Greece?
- Estonia, at 68.0% against 68.0% in Greece as of 2022.
- What is the difference in access to anti-retroviral drugs, male between Estonia and Greece?
- 0.0%, with Estonia ahead.
- How many years of comparable data are there for Estonia and Greece?
- 23 years are reported by both, from 2000 to 2022.
- How do Estonia and Greece rank globally for access to anti-retroviral drugs, male?
- Estonia ranks 73rd and Greece ranks 73rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.